Paragangliomas Withdrawn Phase 1 / 2 Trials for Lutetium Lu 177 dotatate (DB13985)

Also known as: Paraganglioma / Paraganglion neoplasm / Paraganglion neoplasm NOS / Neoplasm of paraganglion (disorder) / [M]Paraganglioma NOS (morphologic abnormality) / Gangliocytic paraganglioma (disorder) / Gangliocytic paraganglioma (morphologic abnormality) / Paraganglioma (morphologic abnormality) / Paraganglioma (disorder)

IndicationStatusPhase
DBCOND0051744 (Paragangliomas)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03923257Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and AdolescentsTreatment